All Sauce from Weekly Sauce:

Too few people are getting screened for lung cancer. This is the message from the American Lung Association’s 2022 “State of Lung Cancer” report. Less than 6% of eligible Americans have been screened for lung cancer, and in some states, lung cancer screening rates are as low as 1%. In 2021, the U.S. Preventive Services…  read on >  read on >

TUESDAY, Nov. 15, 2022 (HealthDay News) – Singer Roberta Flack has the incurable disease ALS and can’t sing, but she plans to stay active on other projects, her manager said Monday. Flack, 85, is a Grammy winner best known for hits that include “Killing Me Softly With His Song” and “The First Time Ever I…  read on >  read on >

U.S. stillbirth rates still need to be tackled at the local, state and national levels because efforts to reduce the risk have stalled, new research claims. Racial disparities remain as well, with Black women more likely to experience stillbirth (the loss of a baby before or during delivery) than white women. “Over the last 40…  read on >  read on >

Patients with advanced ankle osteoarthritis have two surgical options to restore their quality of life, and the good news is a new study shows both have good outcomes. Deciding which one is better depends on the patient. “Our aim in this trial was to provide the data that patients need to make informed decisions about…  read on >  read on >

Extracurricular activities may have many benefits for young children, but researchers have discovered racial gaps in who takes part. Among a group of 401 kindergarten students in Ohio, white children were 2.6 times more likely to participate in the most common extracurricular sports than children of other races and ethnicities. The study found similar results…  read on >  read on >

Moderna, Inc., announced Monday that its updated booster shot triggers strong antibody responses against three Omicron subvariants. “We are pleased to see that both of our bivalent booster vaccine candidates offer superior protection against Omicron BA.4/BA.5 variants compared to our original booster, which is encouraging given COVID-19 remains a leading cause of hospitalization and death…  read on >  read on >